Akorn, Inc.

Rating: 0 - Write A Review
1925 West Field Court
Lake Forest, IL 60045
About Akorn, Inc.
  • Akorn is a specialty pharmaceutical company engaged in the development, manufacturing, and marketing of branded and multi-source pharmaceutical products. Akorn has been a leader in specialty pharmaceutical markets since 1971 and is listed on the NASDAQ exchange under the symbol AKRX.

    Akorn operates a contract manufacturing business with the capability and capacity to offer value to pharmaceutical companies looking to outsource manufacturing. Akorn has established contract manufacturing business relationships with large and small pharmaceutical organizations. Akorn has two manufacturing facilities in Decatur, Illinois and Somerset, New Jersey with the capability to produce: Ophthalmic Solutions, Gels and Ointments, and Injectable pharmaceutical products. Our facilities can manufacture pharmaceuticals that require either aseptic processing or terminal sterilization. Akorn has invested in a new state-of-the-art lyophilization manufacturing suite that includes two 220 square foot Serail lyophilizers. Akorn possess the capability and capacity to manufacture lyophilized products in several therapeutic drug categories.
Competitors of Akorn, Inc.
  • Baxter BioPharma Solutions

    With more than 85 years as a parenterals specialist, Baxter’s BioPharma Solutions business offers contract manufacturing form/fill/finish services and solutions for injectables designed to meet complex and traditional sterile manufacturing challenges. We are a leading contract manufacturer of... Read More
  • Edge Pharma

    Edge Pharma is a pharmaceutical sterile and non-sterile 503B Outsourcing Facility offering high quality, innovative solutions for the health care community. Edge Pharma adheres to the values put forth by USP 795, 797, 800, and CGMP. Through this our customers have the confidence in us to deliver... Read More
  • PYRAMID Laboratories , Inc.

    Our mission is to provide clients with Top Quality reliable services assuring that their critically important parenteral products reach patients in need. We offer broad pipeline of services, spanning from preclinical development to commercial manufacturing, combined with 30 years of corporate...
News about Akorn, Inc.
  • Akorn Announces New Extension of Standstill with Lenders and Agrees to Pursue a Sale of its Business Posted

  • Akorn Continues Negotiations with Lenders Posted